Mechanism of action of adapalene for treating EGFR‐TKI‐induced skin disorder by Chihiro Mimura, Tatsuya Nagano, Nanako Miwa, Kanoko Matsumura, Jun Yamada, Hiroki Satoh, Ratoe Suraya, Daisuke Hazama, Daisuke Tamura, Masatsugu Yamamoto, Motoko Tachihara, Yoshihiro Nishimura, Kazuyuki Kobayashi

Subjects: Get full text

Clinical Role of Newly Developed ALBI and mALBI Grades for Treatment of Hepatocellular Carcinoma by Atsushi Hiraoka, Takashi Kumada

Subjects: Get full text

MDM2 Binding Protein Induces the Resistance of Hepatocellular Carcinoma Cells to Molecular Targeting Agents via Enhancing the Transcription Factor Activity of the Pregnane X Recept... by Qiyu Jiang, Qiyu Jiang, Yan Ma, Jingjing Han, Jingdong Chu, Xuemei Ma, Lijun Shen, Bo Liu, Bo-an Li, Jun Hou, Qian Bi

Subjects: Get full text

The multiple‐kinase inhibitor lenvatinib inhibits the proliferation of acute myeloid leukemia cells by Fan Feng, Xiaojuan Li, Ruisheng Li, Boan Li

Subjects: Get full text

When Molecular-Targeted Agents Meet Immunotherapy: The Opportunities for Soft Tissue Sarcoma by Vanina E. Wainsztein, Tom W. Chen

Subjects: Get full text

Simultaneous and Sequential Use of Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Real-World Practice in China by Li J, Huang L, Ge C, Zhu X, Qiu M, Chen C, Wei S, Yan Y

Subjects: Get full text

Analysis of Gene Signatures of Tumor Microenvironment Yields Insight Into Mechanisms of Resistance to Immunotherapy by Ben Wang, Mengmeng Liu, Zhujie Ran, Xin Li, Jie Li, Yunsheng Ou

Subjects: Get full text

Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival by Kyoko Oura, Asahiro Morishita, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Masafumi Ono, Takashi Himoto, Tsutomu Masaki

Subjects: Get full text

Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment by Makoto Chuma, Hideki Yokoo, Atsushi Hiraoka, Kazuhiko Ueda, Takahiro Yokoyama, Kunihiko Tsuji, Noritomo Shimada, Haruki Uojima, Satoshi Kobayashi, Nobuhiro Hattori, Tomomi Okubo, Masanori Atsukawa, Toru Ishikawa, Koichi Takaguchi, Akemi Tsutsui, Hidenori Toyoda, Toshifumi Tada, Yoshinori Saito, Shunji Hirose, Takaaki Tanaka, Kazuhisa Takeda, Masako Otani, Zenjiro Sekikawa, Tsunamasa Watanabe, Hisashi Hidaka, Manabu Morimoto, Kazushi Numata, Tatehiro Kagawa, Michiie Sakamoto, Takashi Kumada, Shin Maeda

Subjects: Get full text

Therapeutic targeting of cancer stem cells by Marcello eMaugeri-Saccà, Ann eZeuner, Ruggero eDe Maria, Ruggero eDe Maria

Subjects: Get full text

Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient‐derived cell invasion via a novel in vivo tumor model by Huiwei Sun, Fan Feng, Hui Xie, Xiaojuan Li, Qiyu Jiang, Yantao Chai, Zhijie Wang, Ruichuang Yang, Ruisheng Li, Jun Hou

Subjects: Get full text

Hepatitis B Virus Reactivation Associated With Therapeutic Interventions by Young Chang, Soung Won Jeong, Jae Young Jang

Subjects: Get full text

Silencing the expression of copine-III enhances the sensitivity of hepatocellular carcinoma cells to the molecular targeted agent sorafenib by Chen Z, Jiang ZK, Zhang WZ, He BX

Subjects: Get full text

Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology by Sandra Mirie Kang, Lana Khalil, Bassel F. El-Rayes, Mehmet Akce

Subjects: Get full text

Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program by Philippe A. Cassier, Clémentine Peyramaure, Valery Attignon, Lauriane Eberst, Camille Pacaud, Sandrine Boyault, Françoise Desseigne, Mathieu Sarabi, Pierre Guibert, Pauline Rochefort, Nathalie Marques, Michel Rivoire, Aurélien Dupré, Patrice Peyrat, Catherine Terret, Isabelle Ray-Coquard, Clélia Coutzac, David Pérol, Jean-Yves Blay, Olivier Trédan, Christelle de la Fouchardière

Subjects: “…Molecular alterations, molecular-targeted agents…”
Get full text

Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma by Sawako Uchida‐Kobayashi, Ken Kageyama, Shigekazu Takemura, Kazuhiro Matsumoto, Naoshi Odagiri, Atsushi Jogo, Kohei Kotani, Ritsuzo Kozuka, Hiroyuki Motoyama, Etsushi Kawamura, Atsushi Hagihara, Akira Yamamoto, Hideki Fujii, Shogo Tanaka, Masaru Enomoto, Akihiro Tamori, Yukio Miki, Shoji Kubo, Norifumi Kawada

Subjects: Get full text

Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma by Mei Luo, Huiwei Sun, Qiyu Jiang, Yantao Chai, Congshu Li, Bin Yang, Zhixian Hong

Subjects: Get full text

Treatment Selection for Early to Intermediate Hepatocellular Carcinoma by Kazuhiro Nouso, Takamasa Ohki, Tatsuya Yamashita, Haruyuki Takaki, Chien-Au Liu, Tae Wook Kang, Dong Ho Lee, So Jung Lee, Suyash Kulkarni, Deepa Shree, Masatoshi Tanaka

Subjects: Get full text

Increased Liquefactive Necrosis Formation After Transarterial Chemoembolization Combined with Molecular Targeted Agents Plus Immune Checkpoint Inhibitors for Hepatocellular Carcino... by Wang Y, Zhou C, Liu J, Shi Q, Huang S, Yang C, Li T, Chen Y, Xiong B

Subjects: Get full text

Genetic/Epigenetic Alteration and Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Transforming the Immune Microenvironment with Molecular-Targeted Agents by Naoshi Nishida, Masatoshi Kudo

Subjects: Get full text